Results 1 to 10 of about 123,621 (353)
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes [PDF]
Journal of Cannabis Research, 2023 Background Since 2001, Canadians have been able to obtain cannabis for medical purposes, initially through the Access to Cannabis for Medical Purposes Regulations (ACMPR).
Cecilia Costiniuk +11 more
doaj +2 more sources
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome [PDF]
Brain and BehaviorBackground Complex regional pain syndrome is characterized by severe, persistent pain. Emerging evidence suggests that cannabis‐based medicinal products may represent a new therapeutic option.
Lilia Evans +10 more
doaj +2 more sources
How older Canadians access medical cannabis and information about it: A descriptive survey [PDF]
Cogent GerontologyTo understand older adults’ perceptions regarding access to medical cannabis and information related to it. We employed cross-sectional survey design to recruit Canadians (≥60 years) who consume cannabis for health purpose(s).
Shovana Shrestha +9 more
doaj +2 more sources
Mayo Clinic Proceedings, 2018 Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United States. Clinicians are increasingly being asked by patients to share information about or certify them for medical cannabis. In order to engage in informed discussions with patients or be comfortable certifying them in states with medical ...
Jon O, Ebbert +2 more
+5 more sources
Rambam Maimonides Medical Journal, 2023 Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting
Nicole Paland +5 more
doaj +1 more source
Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids [PDF]
, 2017 Medical marijuana is increasingly prescribed as an analgesic for a growing number of indications, amongst which terminal cancer and multiple sclerosis. However, the mechanistic aspects and properties of cannabis remain remarkably poorly characterized. In
Gwenny M. Fuhler +8 more
core +11 more sources
Archives of Public Health, 2022 We would like to thank authors Reece and Hulse (2022) for their three-part article titled “Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer ...
Frank Yizhao Chen +2 more
doaj +1 more source
Three Decades of Cannabis Research: What are the Obstacles?
Rambam Maimonides Medical Journal, 2022 During the past few years, thousands of articles have been published concerning medical cannabis useage. Unfortunately, most publications are case studies or small and poorly designed research projects. In attempting to understand the reasons behind this
Michael Dor
doaj +1 more source
The Immunopathology of COVID-19 and the Cannabis Paradigm
Frontiers in Immunology, 2021 Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of ...
Nicole Paland +8 more
doaj +1 more source
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
Frontiers in Immunology, 2022 Cytokine storm refers to the dysregulated production of inflammatory mediators leading to hyperinflammation. They are often detrimental, and worsen the severity of COVID-19 and other infectious or inflammatory diseases.
Miran Aswad +8 more
doaj +1 more source